MEP38508A - Benzofuran derivatives, their preparation and use - Google Patents

Benzofuran derivatives, their preparation and use

Info

Publication number
MEP38508A
MEP38508A MEP-385/08A MEP38508A MEP38508A ME P38508 A MEP38508 A ME P38508A ME P38508 A MEP38508 A ME P38508A ME P38508 A MEP38508 A ME P38508A
Authority
ME
Montenegro
Prior art keywords
alkyl
benzofuran derivatives
preparation
alkenyl
aryl
Prior art date
Application number
MEP-385/08A
Other languages
Bosnian (bs)
English (en)
Croatian (hr)
Inventor
Kim Andersen
Mario Rottlaender
Klaus Peter Boegesoe
Henrik Pedersen
Thomas Ruhland
Robert Dancer
Original Assignee
Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck As filed Critical Lundbeck As
Publication of MEP38508A publication Critical patent/MEP38508A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
MEP-385/08A 1998-12-08 1999-12-03 Benzofuran derivatives, their preparation and use MEP38508A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11136098P 1998-12-08 1998-12-08
DKPA199801631 1998-12-09
PCT/DK1999/000676 WO2000034263A1 (en) 1998-12-08 1999-12-03 Benzofuran derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
MEP38508A true MEP38508A (en) 2011-02-10

Family

ID=43768792

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-385/08A MEP38508A (en) 1998-12-08 1999-12-03 Benzofuran derivatives, their preparation and use

Country Status (18)

Country Link
EP (1) EP1137644B9 (sh)
JP (1) JP2002531556A (sh)
AR (1) AR021509A1 (sh)
AT (1) ATE249451T1 (sh)
AU (1) AU759248B2 (sh)
CA (1) CA2353618A1 (sh)
CZ (1) CZ20012041A3 (sh)
DE (1) DE69911243T2 (sh)
DK (1) DK1137644T3 (sh)
ES (1) ES2204175T3 (sh)
HU (1) HUP0104510A3 (sh)
IL (1) IL143082A (sh)
ME (1) MEP38508A (sh)
PT (1) PT1137644E (sh)
RS (1) RS50065B (sh)
SE (1) SE1137644T5 (sh)
SI (1) SI1137644T1 (sh)
WO (1) WO2000034263A1 (sh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
EA008372B1 (ru) * 2000-07-07 2007-04-27 Х.Лундбекк А/С Применение эсциталопрама для лечения расстройства, связанного с социальной тревогой
EA008373B1 (ru) * 2000-07-07 2007-04-27 Х. Лундбекк А/С Применение эсциталопрама для лечения расстройства, связанного с посттравматическим стрессом
NZ523720A (en) * 2000-07-21 2004-07-30 H Novel compounds and their use as glycine transport inhibitors
AU2001288605A1 (en) * 2000-09-06 2002-03-22 Chugai Seiyaku Kabushiki Kaisha A traceless solid-phase synthesis of 2-imidazolones
US7235569B2 (en) 2003-05-02 2007-06-26 Wyeth Piperidinyl indole and tetrohydropyridinyl indole derivatives and method of their use
US7276603B2 (en) 2003-05-02 2007-10-02 Wyeth Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
US9394285B2 (en) 2013-03-15 2016-07-19 Pfizer Inc. Indole and indazole compounds that activate AMPK

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (sh) * 1965-03-18
GB1173312A (en) * 1966-03-17 1969-12-10 Kefalas As Heterocyclic Compounds
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
AU684874B2 (en) * 1993-12-28 1998-01-08 Pharmacia & Upjohn Company Heterocyclic compounds for the treatment of cns and cardiovascular disorders
ZA954689B (en) * 1994-06-08 1996-01-29 Lundbeck & Co As H 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines

Also Published As

Publication number Publication date
EP1137644B9 (en) 2004-03-17
RS50065B (sr) 2009-01-22
CA2353618A1 (en) 2000-06-15
SE1137644T5 (sh) 2004-05-11
JP2002531556A (ja) 2002-09-24
ES2204175T3 (es) 2004-04-16
EP1137644B1 (en) 2003-09-10
PT1137644E (pt) 2004-01-30
IL143082A (en) 2004-06-20
AU1503600A (en) 2000-06-26
SE1137644T3 (sh) 2003-12-02
HUP0104510A3 (en) 2003-01-28
DK1137644T3 (da) 2003-12-08
AR021509A1 (es) 2002-07-24
SI1137644T1 (en) 2003-12-31
YU38401A (sh) 2005-06-10
DE69911243T2 (de) 2004-07-15
AU759248B2 (en) 2003-04-10
EP1137644A1 (en) 2001-10-04
WO2000034263A1 (en) 2000-06-15
IL143082A0 (en) 2002-04-21
HUP0104510A2 (hu) 2002-04-29
DE69911243D1 (de) 2003-10-16
CZ20012041A3 (cs) 2001-10-17
ATE249451T1 (de) 2003-09-15

Similar Documents

Publication Publication Date Title
DE69710319D1 (de) Para-substituierte phenylpropansäure derivate als integrin-antagonisten
PT96001A (pt) Processo para a preparacao de derivados de isoquinolina condensada com um anel carbociclico
PT1007523E (pt) Derivados indole e 2,3-di-ridroindole, sua preparacao e utilizacao
KR950704294A (ko) 축합 벤조화합물(fused benzo compounds)
ES2191260T3 (es) Derivados de la imidazolidin-4-ona utiles como agentes anticancerosos.
MEP38508A (en) Benzofuran derivatives, their preparation and use
BR9814055B1 (pt) composto, composição farmacêutica, uso do composto, e, processos para preparar e para produzir um composto.
EA200301317A1 (ru) Производные аминохинолина и его применение в качестве лигандов аденозина a3
ATE268751T1 (de) Biphenylamidin-derivate
BR0112043A (pt) Ftalidas substituìdas, processo para sua preparação e composições farmacêuticas contendo-as
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
EP0351385A3 (en) New amidino and guanidino derivatives
DK0408044T3 (da) Antiinflammatorisk og/eller antiallergisk præparat, der omfatter glutathionderivater
MXPA04006113A (es) Derivados de triazoloquinolina utiles como ligandos receptores de adenosina.
ATE86866T1 (de) Antikrebs-zusammensetzung.
ATE402140T1 (de) Cyclopentyl sulfonamid derivaten
ID25477A (id) Turunan-turunan spiropiperidin
ES2055241T3 (es) Compuestos anti-psicoticos.
DK0456183T3 (da) Spiro-dibenzosuberan-derivater
BG105646A (en) Benzofuran derivatives, their preparation and use
DK0420224T3 (da) Anthihepatopatisk middel
EA199901034A3 (ru) Новые соединения 1,2-дитиолана, способ их получения и содержащие их фармацевтические составы
ES533657A0 (es) Un procedimiento para la preparacion de nuevos derivados de pirrolo-(2,1-a)isoquilonina.
RU96120092A (ru) Новые производные пиперазина и способы их получения и содержащие их композиции
DE69828037D1 (de) Pyrroloindol-derivate und zwischenprodukte zu ihrer herstellung